We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A study that shows the level of coronavirus outbreaks and infections in schools.
Guidance and information about high consequence infectious diseases and their management in England.
Advice for health professionals on pregnant women who are inadvertently vaccinated against chicken pox (varicella), shingles or measles, mumps, rubella.
A list of contacts that providers and care recipients can approach to access free PPE, including the PPE Portal, local authorities and local resilience forums.
Guidance on the collection and reporting of data for CTAD, the surveillance system for all chlamydia tests done in England.
A national point prevalence survey on healthcare associated infections (HCAIs), antimicrobial use (AMU) and antimicrobial stewardship (AMS) in England, 2023.
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
Information on the extended 2020 to 2021 flu vaccination programme.
Advice for those working in adult social care on managing your mental health and how employers can take care of the wellbeing of their staff.
Information on where and when eligible people can get their flu vaccination.
How the UK Health Security Agency (UKHSA) applies the Code of Practice for Statistics in publication of the R value and growth rate estimates.
Managing cases of infectious diseases in all education and childcare settings posters.
Statement from Public Health England (PHE) and the National Institute for Health and Care Excellence (NICE) on vitamin D supplementation during winter.
Data showing the seasonality of major respiratory viruses.
Assay intended for use by professionals and trained operators on the SAMBA II instrument system in clinical and point-of-care settings.
The SAMBA II SARS-CoV-2/RSV test is for the qualitative detection of nucleic acids from SARS-CoV-2 and/or Respiratory Syncytial Virus in human respiratory specimens.
This protocol is for the administration of inactivated influenza vaccine to individuals in accordance with the national influenza vaccination programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).